Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Better hair loss models needed for research.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Animal models, especially mice, are essential for advancing hair loss research and treatment.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Early intervention and patient education are crucial for managing alopecia areata.

IL-1α levels are higher in alopecia areata patients, suggesting a role in the disease.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Too much epidermal growth factor can cause hair loss.

Certain RNAs may help diagnose alopecia areata by affecting keratin genes.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

The paper concludes that the patchiness of alopecia areata is likely due to when the immune attack happens in the hair growth cycle.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

The topical treatment reduced hair loss and improved hair growth in patients with certain types of hair loss.

Low vitamin D might be one of several factors involved in the hair loss condition alopecia areata.

Alopecia areata is a skin condition causing hair loss, and its exact cause is unknown, but it may involve biological mechanisms.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

The conference discussed various hair disorders and treatments, including the use of topical steroids, high doses of cetrizine, and hair grafting, as well as the psychological impact of hair loss.